Connect Sign In
2004672
HER2/neu by Immunoassay, Serum
HER2 QUANT
Ordering Recommendation
May be used to monitor metastatic breast cancer in patients. Use in conjunction with other clinical findings.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Plain red or serum separator tube (SST).
Specimen Preparation
Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.2 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Storage/Transport Temperature
CRITICAL FROZEN.
Unacceptable Conditions
Hemolyzed or thawed specimens.
Remarks
Stability
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: Indefinitely
Methodology
Quantitative Chemiluminescent Immunoassay (CLIA)
Performed
Varies
Reported
5-10 days
Reference Interval
By report
Interpretive Data
Compliance Category
Performed by non-ARUP Laboratory
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
83950
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2004673 | HER-2/neu | 42914-2 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- HER-2 Extracellular Domain (ECD); HER-2/neu Shed Antigen
HER2/neu by Immunoassay, Serum
LabCorp
